StockData
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.55−0.12 (-1.24%)

Close on Nov 17, 2026Market cap $359.28MP/E –Yield –

Contineum Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Contineum Therapeutics's enterprise value was $123.71M on Nov 11, 2026, against $110.24M a year earlier. Over the last 3 years it ranged from -$125.26M to $306.71M, with a median of $77.54M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$123.71M+3.3%
2025Dec 31, 2025$119.76M–
2024Dec 31, 2024-$13.57M–

More Contineum Therapeutics figures

See a number that looks wrong?